Celularity Operating Cycle from 2010 to 2026
| CELU Stock | USD 1.30 0.13 11.11% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 256.43 | Current Value 347.18 | Quarterly Volatility 65.11109691 |
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 M, Interest Expense of 7.6 M or Total Revenue of 65.5 M, as well as many indicators such as Price To Sales Ratio of 0.92, Dividend Yield of 0.0 or PTB Ratio of 4.87. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
Celularity | Operating Cycle | Build AI portfolio with Celularity Stock |
The evolution of Operating Cycle for Celularity provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Celularity compares to historical norms and industry peers.
Latest Celularity's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Celularity over the last few years. It is Celularity's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Celularity Operating Cycle Regression Statistics
| Arithmetic Mean | 296.47 | |
| Geometric Mean | 290.79 | |
| Coefficient Of Variation | 21.96 | |
| Mean Deviation | 45.84 | |
| Median | 278.38 | |
| Standard Deviation | 65.11 | |
| Sample Variance | 4,239 | |
| Range | 229 | |
| R-Value | 0.18 | |
| Mean Square Error | 4,368 | |
| R-Squared | 0.03 | |
| Significance | 0.48 | |
| Slope | 2.38 | |
| Total Sum of Squares | 67,831 |
Celularity Operating Cycle History
About Celularity Financial Statements
Celularity shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 256.43 | 347.18 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.